Partnership Approach to Cost-Effective Industrialisation of Drug Delivery Devices - Scaling-Up to Commercial Manufacture of a Novel Dry Powder Inhaler

摘要

The ongoing surge of consolidation among major pharmaceutical companies may increase competition among contract suppliers to the industry as target customers get bigger and fewer, but opportunities still abound for smaller independent companies which are able to co-operate efficiently and effectively.